Stay updated on KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedUpdated page to v3.2.0 with a prominent operating-status notice; removed previous v3.1.0.”SummaryDifference13%
- Check20 days agoChange Detected- Version updated from v3.0.2 to v3.1.0. This indicates a new release/build; no other content changes are indicated.SummaryDifference0.3%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1, indicating a version upgrade. The 'Back to Top' element was removed as a minor UI cleanup.SummaryDifference0.8%
- Check41 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.8%
- Check48 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, as well as multiple study statuses and descriptions, indicating a focus on new research information.SummaryDifference11%
- Check63 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%
Stay in the know with updates to KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial page.